Host-microbiota interactions are vital for diverse pathophysiological events and may be targeted for innovative therapeutics. Nuclear receptors (NRs) are versatile host sensors of microbial signals that coordinate diverse environmental cues with local and remote adaptions. Harnessing NR-mediated sensory machinery could provide an alternative lynchpin for gut microbiota-oriented drug discovery strategy.
Keywords: drug discovery; host–microbe interaction; microbial metabolite; nuclear receptors; target identification.
Copyright © 2021 Elsevier Ltd. All rights reserved.